Lv1
100 积分 2023-11-27 加入
FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1
1天前
已完结
Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression
1天前
已完结
Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis
3个月前
已完结
Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis
3个月前
已完结
The Antiobesity Effects and Potential Mechanisms of Theaflavins
4个月前
已完结
Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver
7个月前
已完结
Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability
8个月前
已完结
Revisiting liver metabolism through acetyl-CoA carboxylase inhibition
8个月前
已完结
EMC10 modulates hepatic ER stress and steatosis in an isoform specific manner
11个月前
已完结
EMC10 modulates hepatic ER stress and steatosis in an isoform specific manner
11个月前
已完结
皖公网安备34019202002308
